SEP 30, 2015 7:30 AM PDT

Humanized NSGTM Mice for Evaluation of Immuno-Oncology Therapeutics

Speakers
  • Technical Information Scientist, The Jackson Laboratory
    Biography
      Brian has worked at The Jackson Laboratory for 20 years. He conducted research on treatment strategies for a mouse model of human enzyme deficiency. Approaches included enzyme replacement, gene therapy, and neonatal allogeneic bone marrow transplantation. He is currently a Technical Information Services Scientist. Brian's area of expertise is in modeling (and complications associated with) human type 1 and type 2 diabetes, and research with immunodeficient mice.

    Abstract:

    Using the NSGTM mouse (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ), JAX In Vivo Pharmacology Services has combined the human CD34+ hematopoietic stem cell engrafted NSGTM (hu-CD34 NSGTM) with human patient derived xenograft (PDX) to create a platform for humanized preclinical studies in immuno-oncology. Non-HLA matched PDX tumors grow well in hu-CD34 NSGTM, despite concerns over transplant rejection. When unmatched human PDX was engrafted in NSGTM or hu-CD34 NSGTM tumor growth rate was similar, indicating the human immune cells did not influence tumor growth. Next, hu-CD34 NSGTM mice were transplanted with a PDX breast or lung tumor in which 56.9% and 89.1% of the cells in the tumor expressed PD-L1, respectively. When PD-L1 is bound to PD1 on T cells, the T cells are rendered anergic. When treated with Keytruda, an antibody that blocks PD1/PD-L1 binding, tumor growth was significantly diminished. This showed human T cells could be induced to respond to PDX following treatment with a check-point inhibitor. Recognizing that CTL’s are not the only cell population important in immuno-oncology, we are now evaluating NSGTM-SGM3 mice (NOD.Cg-Prkdcscid Il2rgtm1Wjl Tg(CMV-IL3,CSF2,KITLG)1Eav/MloySzJ) for humanization and co-engraftment of PDX. These mice express human IL-3, GM-CSF, and KIT ligand that allow improved development of regulatory T cells (Treg) and myeloid cells. Within the tumor, Treg are implicated in suppression of T effector function. Myeloid derived suppressor cells (MDSC) and tumor associated macrophages (TAM) also diminish immune responses. Engraftment kinetics comparing hu-CD34 NSGTM to hu-CD34 NSGTM-SGM3 hosts show more rapid expansion of CD3+ T cells, Treg, and CD33+ myeloid cells in the NSGTM-SGM3 hosts. Several PDX tumors have successfully engrafted in the hu-CD34 NSGTM-SGM3 hosts, enabling further research into both the basic biology and development of therapeutics in human immuno-oncology.


    Show Resources
    You May Also Like
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    AUG 27, 2019 9:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 9:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    FEB 19, 2020 11:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    FEB 26, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    Loading Comments...
    Show Resources